The United States and Mexico, once internationally recognized for eradicating measles as a persistent public health threat, are now under scrutiny by the Pan American Health Organization (PAHO) over the possibility of losing their measles elimination status. The review, which centers on whether the same strain of measles virus has circulated continuously in each country for at least a year, comes after two years marked by mounting outbreaks and falling vaccination rates. Findings are expected as soon as next week, potentially marking a setback for regional disease control efforts.

Achieved in 2000 for the US and 2016 for Mexico, measles elimination status was a landmark in global public health, denoting the interruption of sustained transmission within national borders. But a combination of declining vaccine uptake and viral resurgence is threatening to reverse these hard-won advances.

Genetic Evidence Weighs Heavily

According to the PAHO advisory commission’s ongoing review, genetic evidence suggests that measles has never completely vanished from circulation during the last twelve months in either country. If confirmed, such continuous transmission would prompt the removal of both the United States and Mexico from the list of territories considered measles-free — a fate recently faced by several European and Eurasian countries, including the United Kingdom and Spain (AP, Nov. 13, 2026).

Public Health Crisis by the Numbers

In Mexico, the situation has become especially dire: more than 20,500 measles cases and 50 deaths—primarily among children under five—have been reported this year. Meanwhile, the US has faced multiple simultaneous outbreaks over two years, tallying thousands of cases and around a dozen deaths (AP, Nov. 13, 2026).

This resurgence is linked to a drop in childhood vaccination rates. US vaccine coverage has declined to roughly 92%, noticeably below the 95% threshold required to prevent outbreaks according to public health models. Concerns have been raised about the influence of federal policies and political leadership, specifically noting Health Secretary Robert F. Kennedy Jr. and President Donald Trump, whose approaches critics say have dampened vaccination campaigns and oversight (AP, Nov. 13, 2026).

Calls for Action and Potential Consequences

PAHO’s judgment, if it finds sustained transmission, would be more than symbolic. It threatens to erode decades of progress and raises alarm in a region where measles, before the advent of widespread vaccination, killed and disabled thousands of children annually through complications such as brain swelling and blindness (AP, Nov. 13, 2026).

Public health experts have called for intensified vaccination and educational campaigns. The US Centers for Disease Control and Prevention (CDC) has reemphasized that the elimination designation itself offers no practical protection—only high vaccination rates can shield communities from outbreaks.

With the PAHO’s final determination pending, the coming week may prove decisive for how North America’s largest nations are viewed in the ongoing global struggle to contain vaccine-preventable diseases — and for the health of millions of children who remain at risk.